Breast Carcinoma
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
To define the role of TSP1 in the mammary gland, the steady-state level of TSP1 mRNA in both normal (HB100) and breast cancer cell lines (MCF-7, T47-D, MDA-MB-231, ZR-75-1) was established.
|
8074462 |
1994 |
Malignant neoplasm of breast
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
To define the role of TSP1 in the mammary gland, the steady-state level of TSP1 mRNA in both normal (HB100) and breast cancer cell lines (MCF-7, T47-D, MDA-MB-231, ZR-75-1) was established.
|
8074462 |
1994 |
Non-Small Cell Lung Carcinoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
TSP1 expression was detected in 66.7% (52 of 78) of NSCLCs and in 69.7% (23 of 33) of extraneoplastic lung tissue specimens.
|
9676856 |
1998 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Tumors with low FGF protein expression (< or = 40% of positive cells) presented a number of TSP I cDNA molecules, significantly higher than tumors expressing high levels of FGF protein.
|
9918214 |
1999 |
Non-Small Cell Lung Carcinoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
The aim of this study is to identify and quantitate TSP I and TSP II mRNA in NSCLCs with respect to p53 alterations, angiogenic growth factor expression, and microvascular density.
|
9918214 |
1999 |
Angiogenic Switch
|
0.030 |
Biomarker
|
disease |
BEFREE |
The inverse association we found between TSP I and basic FGF suggests a different role of TSP I and TSP II in the angiogenic "switch," supporting the hypothesis that especially TSP I may have a significant function in tumor angiogenesis.
|
9918214 |
1999 |
Tumor Angiogenesis
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
The inverse association we found between TSP I and basic FGF suggests a different role of TSP I and TSP II in the angiogenic "switch," supporting the hypothesis that especially TSP I may have a significant function in tumor angiogenesis.
|
9918214 |
1999 |
Tumor Cell Invasion
|
0.070 |
Biomarker
|
phenotype |
BEFREE |
TSP-1-mediated tumor cell invasion was almost completely inhibited by either antisense uPAR inhibition or treatment with phospholipase C or epsilon-aminocaproic acid.
|
10090848 |
1999 |
Malignant Pleural Mesothelioma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
TSP-1 was highly expressed in 74 of the 78 MPM tumors (95%) with a mean value of 2.27 +/- 0.42 compared with normal pleura (0.50 +/- 0.06) and surrounding normal lung (0.96 +/- 0.20) (P = 0.05 vs. normal pleura and P = 0.0006 vs. surrounding normal lung).
|
10375104 |
1999 |
Liver carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
TSP-1 was detected in human hepatocarcinoma SK-HEP-1, Hep 3B and immortalized human liver Chang cells.
|
11216860 |
2001 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
TSP-1 immunoreactivity was detected in the extracellular matrix, mostly at the invasion front of the tumor.
|
11253112 |
2001 |
Tumor Cell Invasion
|
0.070 |
Biomarker
|
phenotype |
BEFREE |
TSP-1 immunoreactivity was detected in the extracellular matrix, mostly at the invasion front of the tumor.
|
11253112 |
2001 |
melanoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas.
|
11438469 |
2001 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
In several tumors (thyroid, colon, bladder carcinomas), TSP1 expression is inversely correlated with tumor grade and survival rate, whereas in others (e.g. breast carcinomas), it is correlated with the stromal response and is of little prognostic value.
|
11530335 |
2001 |
Breast Carcinoma
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
In several tumors (thyroid, colon, bladder carcinomas), TSP1 expression is inversely correlated with tumor grade and survival rate, whereas in others (e.g. breast carcinomas), it is correlated with the stromal response and is of little prognostic value.
|
11530335 |
2001 |
Carcinoma
|
0.010 |
AlteredExpression
|
group |
BEFREE |
In several tumors (thyroid, colon, bladder carcinomas), TSP1 expression is inversely correlated with tumor grade and survival rate, whereas in others (e.g. breast carcinomas), it is correlated with the stromal response and is of little prognostic value.
|
11530335 |
2001 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
TSP-1 was suggestive for improved survival in patients with advanced disease; high TSP-1 expression was associated with a median survival of 2.4 years compared to 1.5 years for patients with tumors having a lower degree of TSP-1 expression (P = 0.06).
|
11531279 |
2001 |
Malignant tumor of cervix
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
These findings provide evidence that TSP-1 expression is of value as a prognostic factor in cervical cancer.
|
11555600 |
2001 |
Cervix carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
These findings provide evidence that TSP-1 expression is of value as a prognostic factor in cervical cancer.
|
11555600 |
2001 |
cervical cancer
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
These findings provide evidence that TSP-1 expression is of value as a prognostic factor in cervical cancer.
|
11555600 |
2001 |
Dermatomyositis, Childhood Type
|
0.010 |
Biomarker
|
disease |
BEFREE |
We conclude that the TNF alpha-308A allele indicates directly (or is a surrogate marker of) children with JDM who produce higher concentrations of TNF alpha in response to this undefined inflammatory stimulus, as well as increased concentrations of TSP-1 with resultant small vessel occlusion, contributing to subsequent disease chronicity.
|
11564368 |
2001 |
ovarian neoplasm
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
TSP-1 mRNA expression was detected in 14 out of the 29 malignant epithelial ovarian tumors (48.3%), whereas TSP-2 mRNA expression was detected in 7 malignant epithelial ovarian tumors (24.1%).
|
11712798 |
2001 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Despite this clear reduction in tumor vascularity, the tumor perfusion was the same in TSP-1-transfected tumors and controls.
|
11861403 |
2002 |
Glioma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
This study shows that TSP-1 overexpression slows glioma growth in vivo but does not prevent it from reaching a large size (300 mm(3)).
|
11861403 |
2002 |
Immunologic Deficiency Syndromes
|
0.010 |
Biomarker
|
group |
BEFREE |
Persistence of TSP-1 overexpression was confirmed after three serial s.c. passages of small xenografted tumor blocks of cells stably transfected with TSP-1 cDNA (clones C9 and E7) or vector controls (pooled clones A7-A9) in immunodeficient nu/nu mice.
|
11861403 |
2002 |